Remember how, after getting access to Regeneron's COVID treatment to stave off COVID death in 2020, Trump generously got Chis CHristie, whom he almost killed by infecting him during debate training, the same exclusive access?
November 2, 2025 at 7:08 PM
Remember how, after getting access to Regeneron's COVID treatment to stave off COVID death in 2020, Trump generously got Chis CHristie, whom he almost killed by infecting him during debate training, the same exclusive access?
Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition reut.rs/4cE2nSU
April 18, 2025 at 3:50 PM
Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition reut.rs/4cE2nSU
Regeneron's experimental therapy combo effective in untreated cancer patients reut.rs/48Ih4D3
Regeneron's experimental therapy combo effective in untreated cancer patients
Regeneron said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the disease in previously untreated patients with a type of blood cancer in the first part of a late-stage trial.
reut.rs
December 6, 2025 at 2:40 PM
Regeneron's experimental therapy combo effective in untreated cancer patients reut.rs/48Ih4D3
FREE LINK > Regeneron's gene therapy to treat children born deaf has been approved by the FDA. @gerryfsmith.bsky.social tells the story of its amazing impact on the life of 2-year-old Travis Smith
www.bloomberg.com/news/article...
www.bloomberg.com/news/article...
April 23, 2026 at 6:11 PM
FREE LINK > Regeneron's gene therapy to treat children born deaf has been approved by the FDA. @gerryfsmith.bsky.social tells the story of its amazing impact on the life of 2-year-old Travis Smith
www.bloomberg.com/news/article...
www.bloomberg.com/news/article...
WHO identifies Ebola treatments, vaccines be tested in trials amid outbreak reut.rs/4tYY7EH
WHO identifies Ebola treatments, vaccines be tested in trials amid outbreak
The World Health Organization recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola, including Mapp Biopharmaceutical's MBP134, Regeneron's maftivimab and Gilead Sciences' antiviral remdesivir.
reut.rs
May 29, 2026 at 12:30 AM
WHO identifies Ebola treatments, vaccines be tested in trials amid outbreak reut.rs/4tYY7EH
Children born deaf due to a rare condition can now take a drug to restore their hearing after a new gene therapy was approved in the U.S.
FDA Approves First-Ever Gene Therapy to Restore Hearing
Regeneron’s drug restored hearing in 11 of 12 children in a rare, inherited condition that causes deafness.
on.wsj.com
April 23, 2026 at 6:49 PM
Children born deaf due to a rare condition can now take a drug to restore their hearing after a new gene therapy was approved in the U.S.
Regeneron drops after skin cancer treatment fails late-stage trial reut.rs/4dUl3zd
Regeneron drops after skin cancer treatment fails late-stage trial
Regeneron's shares fell 12% in morning trade on Monday after the company's experimental treatment missed the main goal in a late-stage trial for patients with a type of skin cancer.
reut.rs
May 18, 2026 at 2:45 PM
Regeneron drops after skin cancer treatment fails late-stage trial reut.rs/4dUl3zd
Amgen owes $406 million for monopolizing cholesterol drug market, US jury says reut.rs/4kfu7Qw
Amgen owes $406 million for monopolizing cholesterol drug market, US jury says
A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for engaging in anticompetitive behavior to increase sales of its cholesterol-reduction drug Repatha at the expense of Regeneron's rival drug Praluent.
reut.rs
May 15, 2025 at 9:10 PM
Amgen owes $406 million for monopolizing cholesterol drug market, US jury says reut.rs/4kfu7Qw
Regeneron's experimental antibody helped patients who stopped Wegovy regain about as much muscle as they lost on the drug.
endpoints.news/easd26-regen...
endpoints.news/easd26-regen...
Regeneron's antibody helps patients regain muscle after stopping GLP-1 therapy
Regeneron's trevogrumab helped Wegovy patients regain lost lean mass after stopping the GLP-1, with a 75 mg dose cutting muscle loss in Ph2.
endpoints.news
October 1, 2026 at 6:53 PM
Regeneron's experimental antibody helped patients who stopped Wegovy regain about as much muscle as they lost on the drug.
endpoints.news/easd26-regen...
endpoints.news/easd26-regen...
US FDA declines to approve Regeneron's blood cancer therapy for second time reut.rs/4fdFZRG
US FDA declines to approve Regeneron's blood cancer therapy for second time
Regeneron said on Friday the U.S. Food and Drug Administration has once again declined to approve its blood cancer therapy, this time in relation to observations from the regulator's inspection at a third-party manufacturing site.
reut.rs
August 1, 2025 at 2:25 PM
US FDA declines to approve Regeneron's blood cancer therapy for second time reut.rs/4fdFZRG
incredible news: the U.S. FDA has officially approved Regeneron’s groundbreaking gene therapy for genetic hearing loss, and it will be offered FREE in the U.S.! 👏
April 23, 2026 at 9:05 PM
incredible news: the U.S. FDA has officially approved Regeneron’s groundbreaking gene therapy for genetic hearing loss, and it will be offered FREE in the U.S.! 👏
Regeneron's chief scientist, George Yancopoulos, has some thoughts about the use of AI in medicine.
www.statnews.com/2026/01/15/r...
www.statnews.com/2026/01/15/r...
Regeneron’s chief scientist on Trump’s drug pricing policy, gene therapy, and the problem with AI
Regeneron's chief scientist, George Yancopoulos, has some thoughts about the use of AI in medicine.
www.statnews.com
January 15, 2026 at 5:26 PM
Regeneron's chief scientist, George Yancopoulos, has some thoughts about the use of AI in medicine.
www.statnews.com/2026/01/15/r...
www.statnews.com/2026/01/15/r...
23andMe plans to hold a new auction for its DNA data, opening with a $305M bid led by Anne Wojcicki, after the ex-CEO challenged Regeneron's winning bid in May (Steven Church/Bloomberg)
Main Link | Techmeme Permalink
Main Link | Techmeme Permalink
June 5, 2025 at 4:51 AM
23andMe plans to hold a new auction for its DNA data, opening with a $305M bid led by Anne Wojcicki, after the ex-CEO challenged Regeneron's winning bid in May (Steven Church/Bloomberg)
Main Link | Techmeme Permalink
Main Link | Techmeme Permalink
Does weight loss have to mean muscle loss?
A new experimental drug from Regeneron reduced muscle loss by half when paired with semaglutide, compared with semaglutide alone.
Learn more: www.emjreviews.com/emj-gold/new...
A new experimental drug from Regeneron reduced muscle loss by half when paired with semaglutide, compared with semaglutide alone.
Learn more: www.emjreviews.com/emj-gold/new...
Regeneron's new experimental weight-loss drug cuts muscle loss
Regeneron’s trevogrumab halved muscle loss by half when taken alongside semaglutide in an obesity trial. Read more.
www.emjreviews.com
October 1, 2026 at 2:58 PM
Does weight loss have to mean muscle loss?
A new experimental drug from Regeneron reduced muscle loss by half when paired with semaglutide, compared with semaglutide alone.
Learn more: www.emjreviews.com/emj-gold/new...
A new experimental drug from Regeneron reduced muscle loss by half when paired with semaglutide, compared with semaglutide alone.
Learn more: www.emjreviews.com/emj-gold/new...
"The billionaire biotech firebrand, who has been Regeneron’s chief scientific officer since its founding 37 years ago, sees both AI and stem cells as examples of powerful tools that also suffer from over-the-top promises."
Via @andrewedunn.bsky.social
endpts.com/regeneron-cs...
Via @andrewedunn.bsky.social
endpts.com/regeneron-cs...
'No miracles': What Regeneron's George Yancopoulos really thinks of AI
SAN FRANCISCO — Just over 20 years ago, the people of California voted to spend billions of dollars on an exciting new idea to remake medicine. Agreeing to
endpts.com
January 22, 2025 at 6:16 PM
"The billionaire biotech firebrand, who has been Regeneron’s chief scientific officer since its founding 37 years ago, sees both AI and stem cells as examples of powerful tools that also suffer from over-the-top promises."
Via @andrewedunn.bsky.social
endpts.com/regeneron-cs...
Via @andrewedunn.bsky.social
endpts.com/regeneron-cs...
Really happy to write about some good news for once: Results from a small trial of Regeneron's gene therapy for a rare form of congenital deafness, published yesterday in NEJM, look very promising. My latest for @opinion.bloomberg.com (🎁link):
A New Gene Therapy for Deafness Looks Promising
On her mother’s instruction, a toddler gives her pink stuffed horse, Snap Snap, a big cuddle. Then, as told, she plants a kiss on his soft fur and, because he’s hungry, feeds him a pretend bowl of foo...
www.bloomberg.com
October 13, 2025 at 1:44 PM
Really happy to write about some good news for once: Results from a small trial of Regeneron's gene therapy for a rare form of congenital deafness, published yesterday in NEJM, look very promising. My latest for @opinion.bloomberg.com (🎁link):
The FDA on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. The drugmaker said it will offer the drug for free to U.S. patients.
www.nbcnews.com/health/healt...
www.nbcnews.com/health/healt...
FDA approves first gene therapy for genetic hearing loss
In an unusual move, the drugmaker Regeneron is making the treatment available for free to patients in the United States.
www.nbcnews.com
April 24, 2026 at 2:43 AM
The FDA on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. The drugmaker said it will offer the drug for free to U.S. patients.
www.nbcnews.com/health/healt...
www.nbcnews.com/health/healt...
Exclusive: Anne Wojcicki is poised to regain control of 23andMe, after a nonprofit she controls topped Regeneron’s bid for the DNA testing company.
Anne Wojcicki Wins Bidding for 23andMe
Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a higher bid.
on.wsj.com
June 13, 2025 at 8:29 PM
Exclusive: Anne Wojcicki is poised to regain control of 23andMe, after a nonprofit she controls topped Regeneron’s bid for the DNA testing company.
Lawrence points this out in the replies, but it's worth noting that when Trump got COVID in October 2020, he was treated with Regeneron's (at the time unapproved by the FDA) cocktail of antibodies thanks to a similar "compassionate use" request. They gave him 8 freaking grams of it, even
June 23, 2026 at 4:25 PM
Lawrence points this out in the replies, but it's worth noting that when Trump got COVID in October 2020, he was treated with Regeneron's (at the time unapproved by the FDA) cocktail of antibodies thanks to a similar "compassionate use" request. They gave him 8 freaking grams of it, even
Thinking big: Regeneron's George Yancopoulos wants to cure allergies. He talked about his goals today at @statnews.bsky.social's #STATBreakthrough summit. www.statnews.com/2024/03/21/r...
March 21, 2024 at 7:36 PM
Thinking big: Regeneron's George Yancopoulos wants to cure allergies. He talked about his goals today at @statnews.bsky.social's #STATBreakthrough summit. www.statnews.com/2024/03/21/r...
Sources: Anne Wojcicki is poised to regain control of 23andMe, after her nonprofit TTAM offered $305M to top Regeneron's bid for the DNA-testing company (Wall Street Journal)
Main Link | Techmeme Permalink
Main Link | Techmeme Permalink
June 13, 2025 at 8:25 PM
Sources: Anne Wojcicki is poised to regain control of 23andMe, after her nonprofit TTAM offered $305M to top Regeneron's bid for the DNA-testing company (Wall Street Journal)
Main Link | Techmeme Permalink
Main Link | Techmeme Permalink
He also promised we would all have access to Regeneron’s monoclonal antibody therapy during COVID. The treatments he got were $100k per dose. He’s probably getting a % on the medbed sales for giving them free advertising. I wonder into whose account the Trillion $ in tariffs have gone.
September 28, 2025 at 2:09 PM
He also promised we would all have access to Regeneron’s monoclonal antibody therapy during COVID. The treatments he got were $100k per dose. He’s probably getting a % on the medbed sales for giving them free advertising. I wonder into whose account the Trillion $ in tariffs have gone.
Regeneron's chief scientist is not always impressed by AI, and points to the Covid-era treatment given to President Trump as an example of why. Via @matthewherper.bsky.social
www.statnews.com/2026/01/15/r...
www.statnews.com/2026/01/15/r...
January 15, 2026 at 3:03 PM
Regeneron's chief scientist is not always impressed by AI, and points to the Covid-era treatment given to President Trump as an example of why. Via @matthewherper.bsky.social
www.statnews.com/2026/01/15/r...
www.statnews.com/2026/01/15/r...
LAG-3 takes another hit as Regeneron's skin cancer trial fails in Phase 3.
endpoints.news/regenerons-p...
endpoints.news/regenerons-p...
Regeneron's Phase 3 skin cancer miss adds to mounting failures in LAG-3
Regeneron Pharmaceuticals’ LAG-3 inhibitor called fianlimab has flunked a late-stage skin cancer trial, marking yet another blow for the drug class.
endpoints.news
May 18, 2026 at 1:19 PM
LAG-3 takes another hit as Regeneron's skin cancer trial fails in Phase 3.
endpoints.news/regenerons-p...
endpoints.news/regenerons-p...